FIELD: medicine, pharmacy.
SUBSTANCE: method refers to medicine, namely to the treatment of bronchial asthma. For this purpose, 10-25 mg of surfactant-BL are additionaly inhaled once in a day alongside with bronchodilators and glucocorticosteroids, not earlier than 30 minutes after their administration, course duration is 10-12 days. Then within 3-6 weeks, 10 mg of surfactant is injected once in two days. In case of exacerbation of the disease 5-6 inhalations of 25 mg of surfactant-BL are performed daily, and, if necessary, in combination with inhaled corticosteroids and bronchodilators.
EFFECT: surfactant administration provides increased remission of the disease and can significantly reduce the amount of inhaled corticosteroids and bronchodilators.
2 cl, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2600833C1 |
METHOD OF TREATING CHRONIC OBSTRUCTIVE BRONCHITIS | 2015 |
|
RU2600822C1 |
TREATMENT OF PATIENTS SUFFERING FROM BRONCHIAL ASTHMA | 2008 |
|
RU2356574C1 |
TREATMENT OF PATIENTS SUFFERING FROM BRONCHIAL ASTHMA | 2008 |
|
RU2356544C1 |
METHOD OF REHABILITATION OF PATIENTS WITH BRONCHIAL ASTHMA | 2018 |
|
RU2717708C1 |
METHOD OF TREATMENT OF STEROID-DEPENDENT BRONCHIAL ASTHMA | 2007 |
|
RU2348431C1 |
INDIRECT METHOD FOR TREATING THE PATIENTS SUFFERING FROM BRONCHIAL ASTHMA | 1996 |
|
RU2099071C1 |
PREPARATION FOR TREATMENT OF BRONCHIAL ASTHMA AND METHOD FOR ITS TREATMENT | 2000 |
|
RU2162322C1 |
METHOD FOR TREATMENT OF PULMONARY DISEASES | 1993 |
|
RU2077881C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF BRONCHIAL ASTHMA | 2008 |
|
RU2391663C1 |
Authors
Dates
2017-02-21—Published
2015-09-03—Filed